Prostate cancer - genetic and other markers

Table of Contents

Alternative Names

AMACR


Information

In 2006, it is estimated that 234,460 men will be diagnosed with prostate cancer, and 27,350 will die from their disease. Prostate cancer is the most common malignancy in men and is the third leading cause of cancer-related death in men (behind lung cancer and colon cancer). In an effort to lower these numbers, researchers are investigating many possible markers for prostate cancer. These markers may one day help identify men at higher risk.

  • < Page
  • 1 2
  • >

Review Date: 05/26/2006
Reviewed By: Rita Nanda, M.D., Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, IL. Review provided byVeriMed Healthcare Network.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org)